--- title: Buy Ofev (Nintedanib) 100mg Caps Online description: Ofev (Nintedanib) 100mg capsules treat idiopathic pulmonary fibrosis. Get it securely from our online pharmacy with assured quality and swift delivery. type: product language: en url: https://medsforsale.net/buy-ofev-online-en availability: in_stock price_min: 192.99 price_max: 1378.99 currency: USD offers: - name: 100mg x 30 caps price: 192.99 - name: 100mg x 60 caps price: 329.99 - name: 100mg x 90 caps price: 454.99 - name: 100mg x 120 caps price: 550.99 - name: 100mg x 180 caps price: 1378.99 --- # Buy Ofev (Nintedanib) 100mg Caps Online Ofev, containing Nintedanib, is a kinase inhibitor developed by Boehringer Ingelheim. It slows the decline in lung function for adults with idiopathic pulmonary fibrosis, a progressive lung disease causing scarring. Also used for certain other chronic fibrosing interstitial lung diseases. Order Ofev 100mg caps through our trusted online pharmacy. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **100mg** | 30 caps | **$192.99** | $6.43 | In Stock | | **100mg** | 60 caps | **$329.99** | $5.50 | In Stock | | **100mg** | 90 caps | **$454.99** | $5.06 | In Stock | | **100mg** | 120 caps | **$550.99** | $4.59 | In Stock | | **100mg** | 180 caps | **$1378.99** | $7.66 | In Stock | [Buy Now](https://medsforsale.net/buy-ofev-online-en) ## Introduction Ofev (generic name Nintedanib) is an orally administered capsule approved for the treatment of several progressive fibrotic lung disorders. Manufactured by Boehringer Ingelheim, the medication is supplied in 100 mg hard-filled capsules. It belongs to the class of tyrosine-kinase inhibitors that target pathways implicated in tissue scarring and abnormal blood-vessel growth. In addition to its primary indications for idiopathic pulmonary fibrosis (IPF) and other chronic fibrosing interstitial lung diseases (CF-ILD) with a progressive phenotype, Ofev is also approved for systemic-sclerosis-associated interstitial lung disease (SSc-ILD). Clinical investigation has explored its utility in certain cancers and other fibrotic conditions, but those uses remain off-label. --- ## What is Ofev? Ofev is the generic version of well-known medications, containing the active compound Nintedanib. [our online pharmacy](https://medsforsale.net/buy-ofev-online-en) provides this generic alternative as a cost-effective treatment option. Nintedanib is a small-molecule inhibitor of multiple receptor tyrosine kinases, chiefly those for vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and fibroblast growth factor (FGF). The drug was first approved in the European Union in 2014 for idiopathic pulmonary fibrosis and later received United States FDA approval in 2019. Boehringer Ingelheim markets the branded formulation under the name Ofev; other regions may recognize it as Vargatef when used for non-small-cell lung cancer (NSCLC). --- ## How Ofev Works Nintedanib interferes with three key signalling pathways that drive fibroblast activation, extracellular-matrix deposition, and abnormal angiogenesis: * **VEGF-R inhibition** reduces pathological blood-vessel formation that can perpetuate tissue injury. * **PDGF-R inhibition** limits recruitment and proliferation of fibroblasts and myofibroblasts, the cells responsible for scar tissue. * **FGF-R inhibition** curtails the production of growth factors that further stimulate fibroblast activity. By simultaneously blocking these receptors, Ofev attenuates the cascade that leads to progressive scarring of the lung interstitium. Pharmacokinetic studies show peak plasma concentrations about 2-4 hours after oral intake, with a terminal elimination half-life of roughly 10 hours, allowing twice-daily dosing. The drug is primarily metabolised by esterases and excreted unchanged in the feces; hepatic clearance is limited, though liver enzymes can be modestly elevated. --- ## Conditions Treated with Ofev **Idiopathic Pulmonary Fibrosis (IPF)** - A chronic, irreversible lung disease characterised by diffuse fibrosis and declining lung function. Randomised controlled trials (e.g., INPULSIS-1/2) demonstrated that Ofev reduces the annual rate of forced vital capacity (FVC) decline by ≈50 % compared with placebo, translating into slower disease progression. **Chronic Fibrosing Interstitial Lung Diseases (CF-ILD) with a Progressive Phenotype** - Includes a spectrum of non-IPF disorders (e.g., fibrotic hypersensitivity pneumonitis, idiopathic nonspecific interstitial pneumonia). The INBUILD trial showed a similar attenuation of FVC loss, supporting regulatory approval for this broader indication. **Systemic-Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)** - Patients with systemic sclerosis often develop lung fibrosis that limits survival. The SENSCIS trial found that Ofev reduced the rate of FVC decline by 44 % versus placebo, establishing its benefit in this specific autoimmune context. The therapeutic rationale across these conditions is the same: inhibition of pro-fibrotic signalling slows the deposition of scar tissue, preserving lung capacity and quality of life. --- ## Off-Label and Investigational Uses of Ofev * **Non-Small-Cell Lung Cancer (NSCLC) - Second-Line Therapy** - In the European Union, Nintedanib (branded Vargatef) is approved in combination with docetaxel for advanced NSCLC after first-line failure. While Ofev’s formulation is the same active molecule, its use for cancer is off-label in jurisdictions where only the pulmonary indications are licensed. Clinical data (LUME-Lung 1) demonstrated a modest overall-survival benefit, especially in adenocarcinoma histology. * **Progressive Systemic Sclerosis without Lung Involvement** - Small pilot studies have explored whether early anti-fibrotic therapy can modify skin fibrosis. Results are preliminary; efficacy and safety remain unconfirmed. * **Radiation-Induced Lung Fibrosis** - Pre-clinical models suggest that Nintedanib can mitigate fibrosis following thoracic radiotherapy. Human trials are ongoing. * **Chronic Kidney Disease-Associated Fibrosis** - Early phase studies are investigating systemic anti-fibrotic effects beyond the lung. Evidence is limited and not yet conclusive. All off-label applications should be pursued only under the direct supervision of a qualified healthcare provider, with full awareness that regulatory agencies have not formally endorsed these uses. --- ## Is Ofev the Right Medication for You? Ofev is most appropriate for adults with a confirmed diagnosis of one of the approved fibrotic lung diseases who exhibit a progressive decline in lung function despite standard care. Suitability is enhanced when: * Baseline liver function tests are within normal limits (ALT/AST ≤ 1.5 × ULN). * The patient can adhere to twice-daily dosing with meals, as food improves tolerability. * There are no contraindicating concomitant medications that strongly induce or inhibit CYP3A4 or P-glycoprotein. **Contraindications** include: * Known hypersensitivity to Nintedanib or any capsule excipients. * Severe hepatic impairment (Child-Pugh C). * Pregnancy or breastfeeding, because fetal risk cannot be excluded. Patients with uncontrolled cardiovascular disease, active bleeding disorders, or a history of gastrointestinal perforation should be evaluated carefully before initiation. --- ## Risks, Side Effects, and Interactions ### Common - **Diarrhea** - Occurs in >60 % of patients; usually mild to moderate. - **Nausea and vomiting** - Reported in 20-30 % of users. - **Abdominal pain** - Often accompanies gastrointestinal upset. - **Elevated liver enzymes (ALT, AST)** - Seen in ≈15 % of patients; routine monitoring is recommended. ### Rare - **Hepatobiliary injury** - Severe transaminase elevation or hepatitis in <1 % of cases. - **Bleeding events** - Minor epistaxis or bruising; heightened risk when combined with anticoagulants. - **Hypertension** - Documented in a small subset, generally manageable with standard antihypertensives. ### Serious - **Serious hepatic dysfunction** - Rare cases of fulminant hepatitis requiring discontinuation. - **Severe gastrointestinal perforation** - Extremely uncommon but life-threatening; immediate medical attention required. - **Cardiovascular events** - Myocardial infarction or stroke have been reported, particularly in patients with pre-existing risk factors. #### Drug-Drug Interactions - **Strong CYP3A4 inhibitors** (e.g., itraconazole, clarithromycin) can increase Nintedanib exposure; dose reduction or avoidance is advised. - **Strong CYP3A4 inducers** (e.g., rifampicin, carbamazepine) may reduce efficacy; alternative therapies should be considered. - **P-glycoprotein inhibitors** (e.g., verapamil) may raise plasma levels. - **Anticoagulants/antiplatelet agents** - Combined use may augment bleeding risk; monitor coagulation parameters closely. #### Drug-Food Interactions - Ofev should be taken **with food** (preferably a main meal) to improve absorption and reduce gastrointestinal side effects. - Grapefruit juice, a moderate CYP3A4 inhibitor, is best avoided. --- ## Use: Dosing, Missed Dose, Overdose **Standard dosing** for the approved pulmonary indications is **100 mg capsule taken orally twice daily** (total 200 mg/day). In some regions clinicians may start at 150 mg twice daily for IPF, adjusting based on tolerability. Capsules must be swallowed whole; crushing or chewing is not recommended. **Missed dose:** If a dose is forgotten and the scheduled time is more than 6 hours away, take the missed tablet as soon as remembered. Skip the dose if it is almost time for the next scheduled dose; do **not** double-dose to compensate. **Overdose:** Symptoms may include severe diarrhea, nausea, vomiting, and elevated liver enzymes. Management is supportive-activate emesis if within one hour of ingestion, provide intravenous fluids, and monitor hepatic function. No specific antidote exists. **Precautions:** - Avoid alcohol excess, which can exacerbate hepatic stress. - Do not operate heavy machinery or drive if dizziness or gastrointestinal upset occurs. - Store capsules at 15-30 °C (59-86 °F) in a dry place; keep out of reach of children. --- ## FAQ - **What is the appearance of the 100 mg Ofev capsule?** The capsule is opaque, light-blue, and marked with “100 mg” on the body for easy identification. - **Can I travel internationally with Ofev?** Yes. Carry the medication in its original packaging with a copy of the prescription label. Check destination country import rules for oral oncology/respiratory drugs, as some may require a medical certificate. - **Does Ofev interact with herbal supplements like St John’s wort?** St John’s wort is a moderate CYP3A4 inducer and may reduce Nintedanib levels, potentially lowering efficacy. Discuss any supplements with your clinician before use. - **What are the storage requirements in hot climates?** Keep the capsules below 30 °C; in very warm environments, store them in a climate-controlled area or a refrigerator (do not freeze). Moisture can degrade the formulation. - **How does Ofeb’s efficacy compare with pirfenidone for IPF?** Both agents slow FVC decline, but head-to-head trials are lacking. Choice often depends on side-effect profiles: pirfenidone is associated with photosensitivity, whereas Ofev more commonly causes diarrhea. - **Is dose reduction possible if side effects become problematic?** Yes. Many clinicians reduce the dose to 100 mg once daily or 50 mg twice daily under close monitoring, balancing tolerability with disease-control benefits. - **Do liver function tests need to be performed regularly?** Baseline ALT/AST are required before initiation, then every 3 months for the first year, and periodically thereafter, especially if symptoms of hepatic injury arise. - **Can Ofev be taken with food other than a main meal?** A substantial meal (including protein and fat) optimises absorption. Light snacks may not provide the same benefit and could increase gastrointestinal discomfort. - **Why does Ofev sometimes cause hypertension?** VEGF inhibition can lead to reduced nitric oxide production, causing modest increases in vascular resistance. Blood pressure should be monitored, and antihypertensives introduced if needed. - **Is Ofev safe for patients with mild renal impairment?** No dose adjustment is required for creatinine clearance ≥ 30 mL/min, but severe renal dysfunction has not been studied; caution is advised. --- ## Glossary **Tyrosine-Kinase Inhibitor (TKI)** : A class of drugs that block enzymes (tyrosine kinases) responsible for signaling pathways that regulate cell growth, angiogenesis, and fibrosis. **Forced Vital Capacity (FVC)** : The maximal volume of air that can be forcibly exhaled after a full inhalation; a key measure of lung function in fibrotic diseases. **Hepatic Transaminases** : Enzymes (ALT, AST) released into the bloodstream when liver cells are damaged; elevated levels indicate possible liver injury. **Pharmacokinetics** : The study of how a drug is absorbed, distributed, metabolized, and excreted by the body. --- ## Buying Ofev from [our online pharmacy](https://medsforsale.net/buy-ofev-online-en) Patients who encounter cost barriers or limited local availability can obtain Ofev through **[our online pharmacy](https://medsforsale.net/buy-ofev-online-en)**. We source the generic 100 mg capsules directly from licensed, audited manufacturers that meet international quality standards, ensuring each batch matches the reference product’s potency and purity. By operating as a pharmacy-broker service, we negotiate near-manufacturer pricing, which translates into a lower purchase price for you while maintaining rigorous safety checks. Our delivery system provides discreet packaging and reliable tracking, with express options arriving within 7 days to most destinations and standard airmail typically in 3-4 weeks. Because the medication is shipped directly from a regulated overseas pharmacy, you gain access to a treatment that might otherwise be unavailable through traditional retail channels or insurance formularies. Throughout the process, your privacy is protected-no personal health information is disclosed beyond what is required for legitimate shipment. Choosing **[our online pharmacy](https://medsforsale.net/buy-ofev-online-en)** means you receive a verified, cost-effective supply of Ofev, backed by professional handling and a commitment to patient confidentiality. --- ## Disclaimer The details presented about Ofev are intended solely for general education and must not replace personalized medical advice. Treatment decisions-including any off-label applications-should be made only under the direct supervision of a qualified healthcare professional. Readers are assumed to be competent adults capable of informed health choices. [our online pharmacy](https://medsforsale.net/buy-ofev-online-en) makes generic Ofev available for individuals who may have limited access through conventional pharmacies or insurance programs and who seek an affordable alternative. Always consult a medical practitioner before initiating, modifying, or discontinuing any medication.